[2026-11-17] Anticholinergic Burden in Older Patients: An Exploratory Pilot Survey of Knowledge, Attitudes, and Practices Among Physicians in Taiwan

Background: Anticholinergic burden (ACB) is associated with adverse outcomes in older adults. In Taiwan, around 60% of adults aged 65 and over receive an anticholinergic medicine annually. Whether prescribers recognize this risk is unknown. Objective: To describe physicians' knowledge, attitudes, and practices regarding ACB in older patients, and identify the resulting knowledge-practice gaps. Methods: An anonymous online knowledge, attitudes and practices survey, used verbatim in English with permission from a UK study, was distributed to physicians at 92 Taiwanese hospitals (July 2024 and July-September 2025). Respondents aware of the term scored 10 medicines (0-3) against the ACB Calculator. Results: Sixty-two physicians responded, 32 of them were emergency physicians. Only 14 (23%) were aware of the term. Among these 14, the mean number of medicines scored correctly was 1.9 of 10 (median [IQR], 0.5 [0.00-3.75]; range, 0-6), and 7 scored none correctly. Oxybutynin, the only medicine scoring 3, was correct in 2 of 14, while 7 answered 'do not know'. No respondent correctly classified all 10 medicines as having or lacking anticholinergic activity. Delirium was recognized by 6 of 14, but all 7 who answered selected urinary incontinence, which is not an anticholinergic adverse effect. Thirty-one of 60 (52%) rated assessment as important or very important, 23 were neutral, and 56 of 62 (90%) wanted further education. Of the 28 who prescribed anticholinergic medicines, 21 never calculated a burden score, 14 never considered ACB, and one did both routinely. Conclusions: Most physicians were unaware of ACB and about half regarded it as important. Closing this gap will require education and prescribing decision support rather than awareness alone.

Authors

Institutions

Publication Details

Journal
Research Medical Journal
Published
2026-11-17
DOI
https://doi.org/10.33165/rmj.2028.e282688
Primary Topic
Pharmaceutical Practices and Patient Outcomes
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

[2026-11-17] Anticholinergic Burden in Older Patients: An Exploratory Pilot Survey of Knowledge, Attitudes, and Practices Among Physicians in Taiwan

Nantawarn Kitikannakorn, Piyawat Dilokthornsakul, Kun‐Pin Hsieh, Phil Moss et al.
3 links
Research Medical Journal
Pharmaceutical Practices and Patient Outcomes
article

[2026-11-17] Anticholinergic Burden in Older Patients: An Exploratory Pilot Survey of Knowledge, Attitudes, and Practices Among Physicians in Taiwan

Nantawarn Kitikannakorn, Piyawat Dilokthornsakul, Kun‐Pin Hsieh, Phil Moss, Phyo Kyaw Myint
article en

Abstract

Background: Anticholinergic burden (ACB) is associated with adverse outcomes in older adults. In Taiwan, around 60% of adults aged 65 and over receive an anticholinergic medicine annually. Whether prescribers recognize this risk is unknown. Objective: To describe physicians' knowledge, attitudes, and practices regarding ACB in older patients, and identify the resulting knowledge-practice gaps. Methods: An anonymous online knowledge, attitudes and practices survey, used verbatim in English with permission from a UK study, was distributed to physicians at 92 Taiwanese hospitals (July 2024 and July-September 2025). Respondents aware of the term scored 10 medicines (0-3) against the ACB Calculator. Results: Sixty-two physicians responded, 32 of them were emergency physicians. Only 14 (23%) were aware of the term. Among these 14, the mean number of medicines scored correctly was 1.9 of 10 (median [IQR], 0.5 [0.00-3.75]; range, 0-6), and 7 scored none correctly. Oxybutynin, the only medicine scoring 3, was correct in 2 of 14, while 7 answered 'do not know'. No respondent correctly classified all 10 medicines as having or lacking anticholinergic activity. Delirium was recognized by 6 of 14, but all 7 who answered selected urinary incontinence, which is not an anticholinergic adverse effect. Thirty-one of 60 (52%) rated assessment as important or very important, 23 were neutral, and 56 of 62 (90%) wanted further education. Of the 28 who prescribed anticholinergic medicines, 21 never calculated a burden score, 14 never considered ACB, and one did both routinely. Conclusions: Most physicians were unaware of ACB and about half regarded it as important. Closing this gap will require education and prescribing decision support rather than awareness alone.

Research Medical Journal
Kaohsiung Medical University (TW), University of Aberdeen (GB), St George’s University Hospitals NHS Foundation Trust (GB), Chiang Mai University (TH)
National Research Council of Thailand
Good health and well-being
Pharmaceutical Practices and Patient Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon